Skip to main content
. 2022 Oct 21;25(Suppl 6):e26009. doi: 10.1002/jia2.26009
Abstract P069 – Table 1. SSP perception of acceptability, appropriateness, and feasibilitya.
Month 1 mean (SD) Month 5 mean (SD) Month 12 mean (SD)
Total Arm‐E Arm‐S Total Arm‐E Arm‐S Total Arm‐E Arm‐S
Acceptability of Implementation Measure (AIM‐Imp) 3.8 (0.76) 3.8 (0.76) 3.9 (0.75) 4.0 (0.72) 4.0 (0.79) 4.1 (0.65) 4.2 (0.71) 4.0 (0.77) 4.3 (0.63)
Implementation Appropriateness Measure (IAM‐Imp) 3.8 (0.77) 3.8 (0.78) 3.9 (0.78) 4.0 (0.74) 3.9 (0.89) 4.2 (0.53) 4.1 (0.70) 3.9 (0.76) 4.2 (0.63)
Feasibility of Implementation Measure (FIM‐Imp) 4.0 (0.64) 4.0 (0.66) 4.0 (0.64) 4.1 (0.72) 4.1 (0.82) 4.2 (0.61) 4.1 (0.73) 4.0 (0.81) 4.3 (0.61)
Acceptability of Intervention (CAB+RPV LA) Measure (AIM‐Int) 4.6 (0.50) 4.6 (0.43) 4.6 (0.56) 4.5 (0.50) 4.5 (0.50) 4.5 (0.51) 4.5 (0.60) 4.5 (0.66) 4.5 (0.55)
Intervention (CAB+RPV LA) Appropriateness Measure (IAM‐Int) 4.2 (0.54) 4.3 (0.53) 4.2 (0.57) 4.3 (0.57) 4.3 (0.43) 4.3 (0.68) 4.3 (0.54) 4.2 (0.47) 4.3 (0.60)
Feasibility of Intervention (CAB+RPV LA) Measure (FIM‐Int) 4.2 (0.56) 4.2 (0.55) 4.3 (0.58) 4.5 (0.49) 4.6 (0.47) 4.5 (0.51) 4.4 (0.60) 4.4 (0.66) 4.4 (0.54)

Arm‐E, Enhanced Arm; Arm‐S, Standard Arm; CAB, cabotegravir; LA, long‐acting; RPV, rilpivirine; SD, standard deviation; SSP, staff study participant.

aAcceptability, appropriateness, and feasibility measures are rated on a 1 to 5 Likert scale: 1 'completely disagree'; 2 'disagree'; 3 'neither agree nor disagree'; 4 'agree'; 5 'completely agree'.